Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2134873
Title:
PROCÉDÉ PERMETTANT DE PRÉDIRE UNE PRÉDISPOSITION À LA PROLONGATION DU QT
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
087446985
WO application number:
US2008058791
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
2134873
WO publication number:
WO2008121899
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
28/03/2008
Grant date:
06/05/2015
EP publication date:
23/12/2009
WO publication date:
09/10/2008
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
06/05/2015
EP B1 publication date:
06/05/2015
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
28/03/2028
Applicant
Name:
Vanda Pharmaceuticals Inc.
Legal Form:
From:
06/05/2015
Address:
2200 Pennsylvania Avenue
Suite 300-E, Washington, DC 20037, United States (US)